Sixpoint Partners, a leading global investment bank serving the middle market, has held the closing of Sheridan Capital Partners Fund II, above its hard cap with $306 million of total capital commitments.
Sheridan Capital Partners (“Sheridan”) is focused on making investments in lower middle market companies in recession resistant, non-discretionary markets within the healthcare industry. The Fund will continue Sheridan’s strategy of making control investments in North American founder-owned businesses with USD3-15 million of EBITDA. Sheridan is led by Partners Jonathan Lewis and Sean Dempsey.
“We are extremely pleased with the overwhelming support provided by our investor base, which encompasses a high-quality group of internationally diversified insurance companies, fund-of-funds, family offices and asset managers,” says Jonathan Lewis, Founder & Partner at Sheridan.
“Sixpoint Partners’ continued strategic advice and support throughout the process were instrumental in the successful outcome of the fundraise,” says Sean Dempsey, Partner at Sheridan.“Sheridan’s oversubscribed sophomore fundraise in a highly selective environment shows a strong vote of confidence in Jonathan, Sean and the rest of the Sheridan team,” says Eric Zoller, Founder & Partner at Sixpoint Partners.
“Sheridan has established itself as a leader in the lower middle market healthcare space and we look forward to a long-term partnership as they continue to generate value for their investors by building differentiated, market-leading platforms within lower middle market healthcare,” says Matt Thornton, Partner at Sixpoint Partners.
Source: Private Equity Wire